Third Point’s Elevance Health ELV Stock Holding History

Third Point’s Portfolio ELV Stock Details ELV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-785,000	Closed	-$172M	–	39
2018 Q1	$172M	Buy	785,000 +410,000	+109%	+$96.3M	1.29%	23
2017 Q4	$84.4M	Sell	375,000 -875,000	-70%	-$186M	0.61%	35
2017 Q3	$237M	Hold	1,250,000	–	–	2%	15
2017 Q2	$235M	Buy	1,250,000 +100,000	+9%	+$18M	2.08%	16
2017 Q1	$190M	Buy	1,150,000 +150,000	+15%	+$23.9M	1.86%	21
2016 Q4	$144M	Buy	+1,000,000	New	+$134M	1.41%	23

Other funds holding ELV

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Baillie Gifford & Co Edinburgh, United Kingdom $97.9B AUM 20.73% 1-Year Est. Return

Viking Global Investors Stamford, Connecticut $35.7B AUM 21.3% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return

First Eagle Investment Management New York $59B AUM 32.99% 1-Year Est. Return

Third Point's ELV Position: Q2 2018 in Review

Third Point sold out of Elevance Health (ELV) in Q2 2018, closing a stake of 785,000 shares — an estimated $172M sold.

Third Point first reported a position in ELV in Q4 2016 and held it in 6 quarters. The position peaked at $237M in Q3 2017. 934 funds tracked by Wall St. Rank hold ELV as of Q2 2018.

Third Point reported no remaining Elevance Health position as of Q2 2018 after selling out during the quarter.
Third Point sold 785,000 Elevance Health shares in Q2 2018, an estimated $172M.
Third Point first reported a position in Elevance Health in Q4 2016 and held it in 6 quarters.
Third Point's Elevance Health position peaked at $237M in Q3 2017.
934 funds tracked by Wall St. Rank held Elevance Health as of Q2 2018.

Based on Third Point's 13F filing for Q2 2018, filed 10 Aug 2018.